Certain evidence can validate the tumor suppressor action of TGF-β, such as the production of angiopoietin 4 in response to TGF-β by receptor-negative breast carcinoma cells in early tumors, which increases the dissemination of these cells as they migrate into the lung capillaries and enter the circulation [58]. The gene discussed is TGFB1; the disease is neoplasm.